The role of tamoxifen in reducing bicalutamide-induced gynaecomastia and breast pain.
Nuttall
Martin C
MC
Princess Royal University Hospital, Bromley Hospitals NHS Trust, Farnborough, Kent, UK.
Harris
James P
JP
Dawkins
Guy P C
GP
D000726:Androgen Antagonists / Q000009:adverse effects*; D000813:Anilides / Q000009:adverse effects* / Q000037:antagonists & inhibitors; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D006177:Gynecomastia / Q000139:chemically induced / Q000188:drug therapy*; D006801:Humans; D008297:Male; D009570:Nitriles; D010146:Pain / Q000139:chemically induced / Q000517:prevention & control*; D011471:Prostatic Neoplasms / Q000188:drug therapy; D013629:Tamoxifen / Q000627:therapeutic use*; D014105:Tosyl Compounds / Q000009:adverse effects* / Q000037:antagonists & inhibitors; D016896:Treatment Outcome
D000726:Androgen Antagonists; D000813:Anilides; D018931:Antineoplastic Agents, Hormonal; D009570:Nitriles; D014105:Tosyl Compounds; D013629:Tamoxifen; C053541:bicalutamide